These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30124346)

  • 1. 5-HT1A receptor ligands and their therapeutic applications: review of new patents.
    Staroń J; Bugno R; Hogendorf AS; Bojarski AJ
    Expert Opin Ther Pat; 2018 Sep; 28(9):679-689. PubMed ID: 30124346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of 5-HT1A receptors: a patent review.
    Lacivita E; Di Pilato P; De Giorgio P; Colabufo NA; Berardi F; Perrone R; Leopoldo M
    Expert Opin Ther Pat; 2012 Aug; 22(8):887-902. PubMed ID: 22788968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.
    Ohno Y
    CNS Neurosci Ther; 2011 Feb; 17(1):58-65. PubMed ID: 21091640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice.
    Bertoni S; Arcaro V; Vivo V; Rapalli A; Tognolini M; Cantoni AM; Saccani F; Flammini L; Domenichini G; Ballabeni V; Barocelli E
    Pharmacol Res; 2014 Mar; 81():17-25. PubMed ID: 24548822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
    Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Serotonin 5-HT
    Newman-Tancredi A; Varney MA; McCreary AC
    Neurochem Res; 2018 May; 43(5):1035-1046. PubMed ID: 29572645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the differential roles of striatal 5-HT
    Meadows SM; Chambers NE; Conti MM; Bossert SC; Tasber C; Sheena E; Varney M; Newman-Tancredi A; Bishop C
    Exp Neurol; 2017 Jun; 292():168-178. PubMed ID: 28342749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.
    Hendry N; Christie I; Rabiner EA; Laruelle M; Watson J
    Nucl Med Biol; 2011 Feb; 38(2):273-7. PubMed ID: 21315283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.
    Ngo T; Nicholas TJ; Chen J; Finch AM; Griffith R
    J Comput Aided Mol Des; 2013 Apr; 27(4):305-19. PubMed ID: 23625023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of heterocyclic-based frameworks as potential scaffold of 5-HT1A receptor agonist and future perspectives: A review.
    Yuan W; Ma Y; Zhang H
    Medicine (Baltimore); 2024 Jun; 103(24):e38496. PubMed ID: 38875413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of 5-HT(1A) receptor agonists and antagonists using GA-SVM method.
    Zhu XL; Cai HY; Xu ZJ; Wang Y; Wang HY; Zhang A; Zhu WL
    Acta Pharmacol Sin; 2011 Nov; 32(11):1424-30. PubMed ID: 21963891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors.
    Wang L; Zhang Y; Du X; Ding T; Gong W; Liu F
    Biomed Pharmacother; 2019 Dec; 120():109408. PubMed ID: 31541883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT
    Guariento S; Franchini S; Tonelli M; Fossa P; Sorbi C; Cichero E; Brasili L
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):214-230. PubMed ID: 28114832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.
    Gomes FV; Del Bel EA; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():43-7. PubMed ID: 23791616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.
    Valhondo M; Marco I; Martín-Fontecha M; Vázquez-Villa H; Ramos JA; Berkels R; Lauterbach T; Benhamú B; López-Rodríguez ML
    J Med Chem; 2013 Oct; 56(20):7851-61. PubMed ID: 24050112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
    Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
    Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher-Affinity Agonists of 5-HT1AR Discovered through Tuning the Binding-Site Flexibility.
    Lian P; Li L; Geng C; Zhen X; Fu W
    J Chem Inf Model; 2015 Aug; 55(8):1616-27. PubMed ID: 26131601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mechanisms for memory enhancement using novel and potent 5-HT1A receptor ligands.
    Pittalà V; Siracusa MA; Salerno L; Romeo G; Modica MN; Madjid N; Ogren SO
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1314-23. PubMed ID: 25963581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.